New RSV Immunization Recommended for Certain At-Risk Infants

Published: 08/16/2023

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care,
  • Rural Health Clinics

The U.S. Centers for Disease Control and Prevention (CDC) has announced that it is recommending a new immunization starting this fall to help protect all infants under 8 months and some older babies at increased risk of severe illness caused by respiratory syncytial virus (RSV).

The CDC recently adopted the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for the use of nirsevimab, trade name BeyfortusTM, a long-acting monoclonal antibody product, to reduce the risk of …

Sign Up for Free Trial